开放获取、知识产权以及生物技术如何成为新的软件科学
Open Access, Intellectual Property, and How Biotechnology Becomes a New Software Science
摘要:
制药行业的创新正在大幅放缓。这里考虑的是,问题的一部分是由于过度限制该部门的知识产权关系。另一方面,计算和软件的特点是知识产权框架非常丰富。计算的知识产权生态系统能否帮助生物科学和生命科学?我们看看答案如何可能是肯定的,通过观察(i)药物在多大程度上反映了软件程序,以及(ii)从生命和生物科学的研究出版趋势中可以收集到什么。
英文摘要:
Innovation is slowing greatly in the pharmaceutical sector. It is considered here how part of the problem is due to overly limiting intellectual property relations in the sector. On the other hand, computing and software in particular are characterized by great richness of intellectual property frameworks. Could the intellectual property ecosystem of computing come to the aid of the biosciences and life sciences? We look at how the answer might well be yes, by looking at (i) the extent to which a drug mirrors a software program, and (ii) what is to be gleaned from trends in research publishing in the life and biosciences.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。